BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/24/2021 9:48:20 AM | Browse: 497 | Download: 1285
 |
Received |
|
2021-04-22 11:00 |
|
Peer-Review Started |
|
2021-04-22 11:00 |
|
First Decision by Editorial Office Director |
|
2021-06-13 13:33 |
|
Return for Revision |
|
2021-06-13 13:33 |
|
Revised |
|
2021-06-27 09:08 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-12-10 06:13 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-12-10 22:58 |
|
Articles in Press |
|
2021-12-10 22:58 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-17 04:02 |
|
Publish the Manuscript Online |
|
2021-12-24 09:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Antonio Gil-Gómez, Ángela Rojas, Chang-Hai Liu, Rocio Gallego-Duran, Rocio Muñoz-Hernandez, Giorgio Fassina, Patrizia Pontisso, Javier Ampuero and Manuel Romero-Gómez |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Sara Borrell postdoctoral fellowships from Instituto de Salud Carlos III to support Ángela Rojas postdoctoral contract |
|
| Consejería de Salud y Familias, Junta de Andalucía supporting Antonio Gil-Gómez contract |
|
| PI19/01404 Grant from Spanish Ministry of Economy, Innovation and Competition, the Instituto de Salud Carlos III |
|
| PI19/00589/Spanish Ministry of Economy, Innovation and Competition, the Instituto de Salud Carlos III |
|
|
| Corresponding Author |
Manuel Romero-Gómez, MD, Full Professor, SeLiver Group, Institute of Biomedicine of Seville, Avda. Manuel Siurot sn, Seville 41013, Spain. mromerogomez@us.es |
| Key Words |
Squamous cell carcinoma antigen; Hepatocellular carcinoma prediction; Precision medicine; Stratification of cirrhotic patient |
| Core Tip |
Current screening programs of hepatocellular carcinoma (HCC) for all cirrhotic patients are controversial and a personalized strategy is an unmet need in the precision medicine era. By studying circulating biomarkers in two-hundred and three cirrhotic patients followed-up for 60 mo, we found that the combination of circulating alpha-fetoprotein and squamous cell carcinoma antigen immunocomplex resulted in a 100% of correctly classified rate identifying a low-risk group of HCC at two years of follow-up in two different cohorts. This predictive model provides a new screening method, which could be followed by tailored HCC surveillance for individual patients. |
| Publish Date |
2021-12-24 09:48 |
| Citation |
Gil-Gómez A, Rojas Á, Liu CH, Gallego-Duran R, Muñoz-Hernandez R, Fassina G, Pontisso P, Ampuero J, Romero-Gómez M. Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients. World J Gastroenterol 2021; 27(48): 8343-8356 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i48/8343.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i48.8343 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
